In Ohio, the Cleveland Clinic joined the Circulating Cell-free Genome Atlas, a national clinical trial that is looking for 7,000 cancer patients and 3,000 healthy patients in the U.S. Their goal is to analyze DNA and RNA in the blood and build a database that will help with detecting cancer early on when it is easier to cure. Researchers believe that using genome sequencing from blood samples could possibly replace x-rays for early cancer detection. Funded by a company in California, GRAIL, Inc., the project will be looking for molecule patterns in the blood for specific types of cancers.
Latest article
History Channel “Ax Man” Buckin’ Billy Ray Smith endorses soy-based chainsaw oil
In Maryland, U.S. Soy and Stanley Black & Decker outdoor brand DEWALT have developed soy-based Bar & Chain Biodegradable Oil for chainsaws and other...
Meatable achieves “cell to sausage” in just 4 days
In the Netherlands, Meatable has reached an important milestone in its efforts to produce cultivated meat at scale—the transformation of pluripotent stem cells into...
Reformation launches castor oil swimwear line
In Los Angeles, popular clothing brand Reformation has released a new swimwear line that emphasizes the use “planet-friendly,” biobased materials.
The company tapped Italy-based...